LATEST ALERTS
Could cannabis help improve outcomes for patients badly afflicted by Covid?
18th August 2022 - Blogs , News analysis |
A study published this month provides further evidence that cannabis could be helpful in treating severe late-stage Covid-19
Health and science
Committee recommendations for CBD products published…
29th July 2022 - Alerts | Canada, North America |
No magic solution: EFSA ingestible CBD safety concerns won’t be resolved quickly
1st July 2022 - Blogs , News analysis |
It looks like there will be no easy or quick solutions to addressing the data gaps the European Food Safety Authority (EFSA) requires to reach a conclusion on the safety of CBD as an ingestible ingredient
Zurich seeks cannabis users for pilot project…
28th June 2022 - Alerts | Europe, Switzerland |
EU novel food applications: the science behind what EFSA says it wants to know
27th June 2022 - News analysis |
The European Food Safety Authority wants more safety data before it approves CBD products as novel food. This is what it wants to know, and why, along with a summary of the science on each point
Canada can teach Germany about pitfalls of legalising recreational cannabis
17th June 2022 - News analysis |
Germany should plan ahead to avoid problems which have plagued governments that have already legalised recreational cannabis on top of medical cannabis
Lack of quality science on cannabis and pain leaves room for fake news and myth
16th June 2022 - Blogs , News analysis |
“It’s a myth that cannabis relieves pain,” declared the Daily Mail. But that is not what the study it was reporting said at all
How do you tell if a user is under the influence? It’s still a testing problem
14th June 2022 - News analysis |
While cannabis use is now legal in many US states, there is as yet no reliable test to determine whether, or how far, a user may be “under the influence”
Lausanne aims to become home to Switzerland’s second cannabis trial
8th June 2022 - News analysis |
Lausanne could become the second Swiss city after Basel to launch a recreational cannabis trial this year. But while Basel’s pilot will involve just 400 participants, Lausanne is aiming for triple that number
Australian companies looking to sell CBD treatments online with prescriptions
8th June 2022 - News analysis |
Companies are trying new ways to reach cannabinoid customers in severely restricted Australia, but they must be careful not to fall foul of strict guidelines that separate promoting from simply informing the public about prescription goods
Off the hook – research reveals youth health benefits of legalising cannabis
31st May 2022 - Blogs , News analysis |
A six-year study of young adult behaviour reveals that when and where cannabis use is legalised, young people’s use of alcoho. and tobacco drops – and so does the use, and misuse, of pain-relieving prescription drugs
Mental health, addiction treatments with psychedelics: could the UK lead the way?
27th May 2022 - News analysis |
Strangely, Brexit and then the Covid-19 pandemic have combined to create ideal conditions for the UK to potentially become a leader in psychedelics research
Pennsylvania medical cannabis vape recall leaves patients stranded
13th May 2022 - News analysis |
A widespread recall of cannabis concentrates sold for vaping at medical cannabis dispensaries in the US state of Pennsylvania has left patients with more questions than answers about who to trust
Argentina approves law to establish legal framework for cannabis and hemp
13th May 2022 - News analysis |
Members of the Argentina Chamber of Deputies approved a law on 5th May that would establish a legal framework for the production, sale and export of medical cannabis as well as industrial hemp, a decision president Alberto Fernández says could generate 10,000 jobs in the South American country
New studies explore how cannabis can help improve women’s menstrual health
12th May 2022 - News analysis |
Clinical trials are investigating how CBD can improve menstrual health and treat conditions such as premenstrual syndrome (PMS) and perhaps even endometriosis
Anxiety and chronic pain are the top reasons for CBD consumption in the UK
10th May 2022 - News analysis |
The most common reasons survey respondents gave for using CBD are for treating anxiety, managing chronic pain, and easing issues with skin conditions
Court orders the return of seized cannabis plants…
10th May 2022 - Alerts | Argentina, South America |
Basel moves forward with its recreational cannabis trial
6th May 2022 - News analysis |
Basel will start allowing the sale of recreational cannabis through local pharmacies at the end of the summer as the first Swiss city to win the approval of health authorities for the pilot project
Psychedelics and mental health research: hope for public and policy support
27th April 2022 - News analysis |
Jamaica is attempting to make itself as synonymous with medical-grade psychedelics in the minds of researchers as it is with cannabis production in the minds of many
Medical cannabis programme introduces new rules…
27th April 2022 - Alerts | North America, Ohio, United States |
The common sense of CBD science, and why it doesn’t always come to the fore
21st April 2022 - Blogs , News analysis |
Is the current system of peer-reviewed journal publication the best way to get the best science on CBD and cannabis? There could be another way
US medical cannabis products: a state-by-state regulatory report
20th April 2022 - Regulatory reports |
This regulatory report analyses the different approaches taken by states over what restrictions they impose on medical cannabis products that patients can buy
So far so good, but German lawmakers urged to go further on medical cannabis
11th April 2022 - News analysis |
Five years after German patients were first allowed to obtain medical cannabis, demand has risen sharply – but there are still some unanswered issues on policy and practice that lobbyists want addressed
Medical cannabis company receives government grant…
8th April 2022 - Alerts | Australasia, New Zealand |
Long trips for a short supply, but there’s optimism in Iowa on medical cannabis
6th April 2022 - News analysis |
Patients in Iowa who rely on supplies of medical cannabis are tightly restricted in how much they can have, and may face a long trip to get it from one of the few licensed dispensaries in the US state
Cannabis a key element in future health planning…
4th April 2022 - Alerts | Argentina, South America |
Hospitals added to authorised cannabis importers…
4th April 2022 - Alerts | Brazil, South America |
Canada’s proposed changes could open up non-therapeutic cannabis research
31st March 2022 - News analysis |
The Canadian government is proposing changes to make it easier to conduct non-therapeutic cannabis research in the country and to foster more investigation into the development of cannabis products
FDA sends CBD companies warning letters over Covid health claims….
31st March 2022 - Alerts | North America, United States |
Could the Pfizer acquisition of Arena be a sign of things to come in Big Pharma?
4th March 2022 - News analysis |
While Big Pharma acquisitions of companies involved in the development of cannabinoid treatments are expected to to propel and expand cannabinoid treatment options, the overall impact of and interest in Big Pharma’s reach into the industry remains a matter of speculation
More medical applications for cannabinoids being explored
4th March 2022 - News analysis |
Scientists around the world are starting to look even further afield for potential uses of cannabis in medical applications, such as treating the symptoms of long Covid-19, Alzheimer’s-related agitation, and to alleviate the pain resulting from HIV
22nd Century Group to make further advances into cannabinoid production
3rd March 2022 - News analysis |
US firm 22nd Century Group plans to use its expertise in plant science, biotechnology and genetics to move further into cannabinoid production
South American legislation on cannabis and hemp will progress, if slowly, in 2022
8th February 2022 - News analysis |
This is an important year for positive legislation affecting cannabinoids across South America, though some depends on election results and all of it will take a few years to take effect
Costa Rica’s president promises to get cannabis legalisation done despite veto
7th February 2022 - News analysis |
Costa Rican president Carlos Alvarado, who has supported the legalisation of cannabis throughout his administration, has partially vetoed a bill that would have legalised medicinal cannabis and industrial hemp
Early research shows some cannabinoids can prevent Covid-19 infecting cells
3rd February 2022 - News analysis |
Research from scientists at the University of Oregon suggests that certain cannabinoids can stop the SARS-CoV-2 (Covid-19) virus from infecting cells. This may lead to future treatments
US lawsuits end DEA restrictions on sources of cannabis for researchers
26th January 2022 - News analysis |
Lawsuits in the US have finally overturned the DEA’s requirement that researchers interested in studying cannabis could only purchase from one source, the University of Mississippi
CBD’s popularity sparks gold rush to develop rare cannabinoids
19th January 2022 - News analysis |
Potential demand for rarer cannabinoids is prompting firms to explore other methods of manufacturing, such as biosynthesis and chemical synthesis, to give higher yields at lower cost
Insurance rule ‘a billion-dollar shot in the arm’ for Colombian cannabis market
11th January 2022 - News analysis |
Colombian insurance providers must now cover the cost of medical cannabis prescriptions, a move that could represent a “billion-dollar shift” in the market – and perhaps lay down a marker for other countries
Colombian insurance policy shows real intent to lead on cannabinoids
6th January 2022 - Blogs , News analysis |
Colombia has joined a select few countries now demanding mandatory coverage of medical cannabis by health insurance providers
Picking the right variety – what seeds are permitted and which grows best where?
31st December 2021 - News analysis |
Desired end product and environmental factors are the two things best kept in mind when considering hemp varieties for different countries
Guidelines on real world data could bring cannabinoid drugs to UK patients sooner
30th December 2021 - News analysis |
New guidance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) on the use of real word data and evidence to support clinical trials could help cannabinoid products gain approval
‘Snake oil’ claims for CBD and Covid-19 top latest list of US FDA warning letters
29th December 2021 - News analysis |
The most common subject of recent warning letters from the US Food and Drug Administration (FDA) over unsubstantiated health claims was CBD products that were claimed to mitigate, prevent, treat, diagnose or cure Covid-19
